NUTRAVITA LIMITED
Get an alert when NUTRAVITA LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-11-11 (in 6mo)
Last made up 2025-10-28
Watchouts
None on the register
Cash
£2M
-31.7% lowest in 7 filed years
Net assets
£8M
+19.2% highest in 5 filed years
Employees
36
+2.9% highest in 5 filed years
Profit before tax
£2M
+83.2% vs 2022
Net assets
8-year trend · vs Consumer Discretionary median
Accounts
8-year trend · latest reflected 2023-12-31
Latest accounts filed cover 2024-12-31; financial figures currently reflect up to 2023-12-31.
| Metric | Trend | 2020-03-31 | 2020-04-01 | 2021-03-31 | 2021-04-01 | 2022-03-31 | 2022-04-01 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | £23,226,435 | — | £22,800,243 | — | £16,977,989 | £33,382,856 | |
| Operating profit | — | — | £4,307,810 | — | £2,662,521 | — | £848,219 | £1,585,594 | |
| Profit before tax | — | — | £4,307,348 | — | £2,657,604 | — | £822,147 | £1,506,549 | |
| Net profit | — | — | £3,491,317 | — | £2,143,931 | — | £647,854 | £1,213,174 | |
| Cash | £2,203,017 | £2,203,017 | £2,562,379 | £2,562,379 | £3,845,789 | — | £2,504,701 | £1,711,102 | |
| Total assets less current liabilities | £27,554 | — | £3,518,871 | — | £5,668,905 | — | £7,234,703 | £8,185,562 | |
| Net assets | £27,554 | — | £3,518,871 | — | £5,662,802 | — | £6,310,656 | £7,523,830 | |
| Equity | £27,554 | — | £3,518,871 | — | £5,662,802 | £5,662,802 | £6,310,656 | £7,523,830 | |
| Average employees | 5 | — | 5 | — | 24 | — | 35 | 36 | |
| Wages | — | — | £192,573 | — | £722,084 | — | £964,590 | £1,829,898 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-03-31 | 2020-04-01 | 2021-03-31 | 2021-04-01 | 2022-03-31 | 2022-04-01 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | 18.5% | — | 11.7% | — | 5.0% | 4.7% | |
| Net margin | — | — | 15.0% | — | 9.4% | — | 3.8% | 3.6% | |
| Return on capital employed | — | — | 122.4% | — | 47.0% | — | 11.7% | 19.4% | |
| Interest cover | — | — | 7252.21x | — | 539.52x | — | 31.97x | 18.85x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Azets Audit Services
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have at the time of approving the financial statements, a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.”
Significant events
- “Supply chain challenges such as rising raw material costs, limited material availability, and ongoing disruptions continue to impact the entire healthcare sector. Additionally, new regulatory requirements, including Extended Producer Responsibility (EPR) and plastic tax frameworks, are adding further complexity to operational planning and compliance.”
- “After the year end EQT VIII SC SP agreed to sell their ownership in the group to a new private equity fund KKR, subject to completion.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 5 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| KUBICA, Susanne Katrin | Director | 2024-11-28 | May 1973 | British |
| LORENZEN, Christoffer Erik Mathies | Director | 2022-01-13 | Dec 1975 | Danish |
| MADSEN, Egil Molsted | Director | 2024-11-28 | Dec 1965 | Danish |
| PEYAMI, Babak | Director | 2014-11-06 | Jun 1987 | British |
Show 5 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BAEYENS, Patrick | Director | 2018-07-23 | 2022-01-13 |
| DE MEDEIROS, Mathieu | Director | 2018-07-23 | 2022-01-13 |
| JONSSON, Jon Sebastian | Director | 2022-01-13 | 2024-11-22 |
| PEYAMI, Arash | Director | 2014-11-06 | 2024-11-22 |
| THYME INVEST BVBA | Corporate Director | 2018-07-23 | 2023-06-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Karo Healthcare Ab | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2022-01-13 | Active |
| Sylphar Nv | Corporate entity | Shares 50–75%, Voting 50–75% | 2018-07-24 | Ceased 2022-01-13 |
| Mr Arash Peyami | Individual | Shares 25–50%, Voting 25–50% | 2016-04-06 | Ceased 2018-07-24 |
| Mr Babak Peyami | Individual | Shares 25–50%, Voting 25–50% | 2016-04-06 | Ceased 2018-07-24 |
Filing timeline
Last 20 of 52 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-11-04 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-14 | AA | accounts | Accounts with accounts type full | |
| 2024-12-03 | AP01 | officers | Appoint person director company with name date | |
| 2024-12-02 | AP01 | officers | Appoint person director company with name date | |
| 2024-11-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-11-29 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-29 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-07 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-10-07 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-09-30 | AA | accounts | Accounts with accounts type full | |
| 2023-11-10 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-09-29 | AA | accounts | Accounts with accounts type full | |
| 2023-08-24 | TM01 | officers | Termination director company with name termination date | |
| 2022-12-21 | AA | accounts | Accounts with accounts type full | |
| 2022-11-14 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-10-11 | AA01 | accounts | Change account reference date company current shortened | |
| 2022-08-17 | AD01 | address | Change registered office address company with date old address new address | |
| 2022-01-21 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2022-01-21 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2022-01-21 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2022 → FY2023 · period ending 2023-12-31 vs 2022-12-31
-
Turnover
+96.6%
£16,977,989 £33,382,856
highest in 4 filed years
-
Cash
-31.7%
£2,504,701 £1,711,102
lowest in 7 filed years
-
Net assets
+19.2%
£6,310,656 £7,523,830
highest in 5 filed years
-
Employees
+2.9%
35 36
highest in 5 filed years
-
Operating profit
+86.9%
£848,219 £1,585,594
-
Profit before tax
+83.2%
£822,147 £1,506,549
-
Wages
+89.7%
£964,590 £1,829,898
highest in 4 filed years
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers